| 000 | 00885 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514052639.0 | ||
| 264 | 0 | _c20021210 | |
| 008 | 200212s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(02)11599-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDukes, M N Graham | |
| 245 | 0 | 0 |
_aAccountability of the pharmaceutical industry. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cNov 2002 |
||
| 300 |
_a1682-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPublic Health |
| 650 | 0 | 4 | _aResearch |
| 650 | 0 | 4 | _aSocial Responsibility |
| 773 | 0 |
_tLancet (London, England) _gvol. 360 _gno. 9346 _gp. 1682-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(02)11599-6 _zAvailable from publisher's website |
| 999 |
_c12263752 _d12263752 |
||